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Background: Analyses in nutritional epidemiology usually assume that there is a uniform 
effect of a nutrient. The purpose of this study was to test whether the effect of β-carotene on 
common cold incidence is uniform over the population.
Methods: The Alpha-Tocopherol Beta-Carotene Study, which recruited male smokers aged 
50–69 years, was conducted in Finland in 1985–1993. The active follow-up lasted for 4.7 years 
(mean). This analysis is restricted to the β-carotene and placebo arms (n = 14,569). The rate 
ratio (RR) of the common cold was modeled as a function of age at follow-up in the β-carotene 
arm compared with the placebo arm using Poisson regression.
Results: Separate regression models in four subgroups of participants were constructed on 
the basis of the age of smoking initiation (#20 years versus $21 years) and baseline smoking 
level (5–14 versus $15 cigarettes/day). In three of the four subgroups, the effect of β-carotene 
was significantly modified by age. Among participants older than 70 years, the extent of 
smoking modified the effect so that β-carotene increased the incidence of colds in those who 
started smoking at an early age and smoked heavily: RR = 1.16 (95% confidence interval [CI]: 
1.02–1.33), but decreased the incidence in those who started smoking at a later age and smoked 
less: RR = 0.76 (95% CI: 0.61–0.94).
Conclusions: The strong evidence of heterogeneity in the β-carotene effect on the incidence 
of colds challenges the validity of cohort studies on nutrients, because they are usually based 
on the assumption of a uniform effect of the nutrient over the studied population.
Keywords: antioxidants, dietary supplements, male, randomized controlled trial, respiratory 
infections
Trial registration: ClinicalTrials.gov NCT00342992.
Introduction
Randomized controlled trials are a much more reliable source for the evaluation of 
intervention effects than observational studies.1 In observational studies, residual 
confounders may always remain, which may generate spurious differences between 
the groups compared.2–4 Because cohort studies are popular for analyzing associations 
between the level of dietary intake of nutrients and the incidence of diseases, the validity 
of cohort studies is a particularly important question in the field of nutrition.
In addition to the problem of residual confounding, another source of misleading 
results in cohort studies is the possible variation in the size of the effect between 
different population groups, ie, effect modification. If the size of the effect varies 





Table 1 Baseline characteristics of participants and the age 
distribution at the follow-up visits; the ATBc Study 1985–1993; 
the no-vitamin e participants










Age of smoking initiation
 #20 years 10,873
 $21 years 3691
Follow-up visits No. of visits
All visits 206,170









between population groups, it may be grossly misleading 
to calculate one  overall estimate of effect and suppose that 
it is valid for all  participants of the study population.
Our previous analyses of the data of the large-scale 
Alpha-Tocopherol Beta-Carotene (ATBC) Study found that 
the effect of vitamin E supplementation on common cold 
incidence was modified by the age at the follow-up visit, 
smoking, and residential neighborhood,5 while the effect on 
pneumonia was modified by age, smoking, age of smoking 
initiation, weight, and dietary vitamin C intake,6–8 and the 
effect on tuberculosis was modified by dietary vitamin C 
intake.9 Given the strong evidence that the effect of vitamin 
E supplementation varies between participant subgroups, it 
is apparent that one single estimate of effect calculated for 
the whole ATBC Study population is misleading in the case 
of these infections.
Several cohort studies have examined the association 
between dietary β-carotene intake and the incidence of 
respiratory tract infections.6,10–12 If the effect of β-carotene 
supplementation on respiratory infections depends on the 
characteristics of people in the same way as the effect of 
vitamin E supplementation does, the uniform effects reported 
in the cohort studies may be misleading.
We previously found that β-carotene supplementation 
had no overall effect on the incidence of pneumonia among 
the ATBC Study participants; however, the effect was signifi-
cantly modified by the age of smoking initiation.6 β-Carotene 
supplementation had no overall effect on the incidence of 
the common cold,10 but significantly increased the incidence 
of colds in a small subgroup of participants who undertook 
heavy exercise during their leisure.13 The purpose of this 
study was to test whether the effect of β-carotene on common 
cold incidence is modified by age in four subgroups of the 
ATBC Study participants as defined by the age of smoking 
initiation and the level of smoking at the baseline of the trial. 
The modification of β-carotene effect by age was examined 
by spline modeling,14 so that the rate ratio (RR) of common 
cold episodes between the β-carotene and placebo arms was 




The design and methods of the ATBC Study examining the 
effects of vitamin E (dl-α-tocopheryl acetate (AT), 50 mg/day 
(50 IU/day)) and β-carotene (BC, 20 mg/day) on the incidence 
of lung and other cancers have been described in detail.15,16 
The ATBC Study is registered at ClinicalTrials.gov under 
the identifier NCT00342992. In brief, the trial participants 
were recruited in 1985–1988 from the total male population 
aged 50–69 living in southwestern Finland. To be eligible, 
participants had to smoke $5 cigarettes per day at entry. 
The eligible participants (n = 29,133) were randomized into 
one of the four intervention arms and administered placebo, 
AT, BC, or AT + BC. The planned intervention continued for 
5–8 years (median 6.1 years) until April 30, 1993, with three 
follow-up visits annually, but because of deaths and dropouts, 
the active follow-up lasted for 4.7 years (mean). The trial 
was approved by the institutional review boards of the par-
ticipating institutions, and all participants gave their written 
informed consent. In this study, I excluded participants who 
were administered vitamin E to avoid problems caused by 
potential interaction between β-carotene and vitamin E.
At the baseline, prior to randomization, all the participants 
completed a questionnaire on their medical and smoking 
histories and general background characteristics. A detailed 
dietary history questionnaire was completed that provided 
data regarding their β-carotene and alcohol consumption.17 
Weight was measured at the baseline. Data on the age 
of smoking initiation were missing for five participants, 
and they were also excluded, so I restricted this study to 
14,564 participants (Table 1).
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Table 2 The effect of β-carotene on common cold incidence; the ATBc Study 1985–1993: participants aged 50–59 years at the 
follow-up visit
Age of smoking  
initiation (years)
Cigarettes/day No. of  
participants




$21 5–14 574 6130 0.292 0.269 1.08 0.98, 1.19
$21 $15 1783 20,554 0.311 0.304 1.02 0.97, 1.08
#20 5–14 1036 10,929 0.315 0.273 1.15 1.08, 1.24
#20 $15 5939 66,237 0.295 0.293 1.00 0.98, 1.04
Notes: each participant visited the study center three times per year for evaluation of whether he had had common cold episodes after the preceding visit. Adding a uniform 
β-carotene effect onto all of the 103,850 visits at the follow-up age of 50–59 years yields rr = 1.030 (95% ci: 1.007, 1.053). Adding an individual β-carotene effect, shown 
in this table, to each of the four subgroups improves the Poisson model by χ2 (3 df) = 14.2, corresponding to P = 0.003. There is a significant interaction between baseline 
smoking and the effect of β-carotene (P = 0.0004) but not between the age of smoking initiation and the effect of β-carotene (P = 0.6). There is no second-order interaction 
between the age of smoking initiation and baseline smoking with the effect of β-carotene (P = 0.2).
Outcome definition
At each follow-up visit to the local study center, three times 
per year at 4-month intervals (Table 1), the participant was 
asked, ‘Have you had a common cold since the previous visit, 
and if so, how many times?’ The occurrence of ‘other upper 
respiratory tract infections’ and ‘acute bronchitis’ was also 
asked about. The number of colds reported at each follow-up 
visit was used as the outcome for this study. This outcome, 
self-reported colds, is based on subjective symptoms and not 
on any laboratory findings. However, because the  subjective 
symptoms lead a person to seek medical attention and obtain 
sick leave, in this respect, the subjective outcome is most 
relevant for public health purposes. The manifestations of the 
common cold are so well known that self-diagnosis by the 
patient is usually correct.18 During 68,723 person-years of 
active follow-up covered by the 4-month visits to the study 
centers, 55,884 common cold episodes were recorded.
Statistical methods
Because the modification of β-carotene effect by age and the 
ATBC Study lasted for some 6 years, the baseline age was 
not used in the current analyses, but the age of the participant 
at the follow-up visit was used instead. This is the biological 
age at the point of time when the outcome for the preceding 
4-month period is evaluated.
The number of common cold episodes was modeled using 
Poisson regression. The RR and the Wald 95% confidence 
interval (CI) were calculated using the SAS PROC GENMOD 
program (release 9.2; SAS Institute, Inc., Cary, NC). Linear 
spline-modeling5,14 was carried out for the four subgroups 
defined by the age of smoking initiation (#20 or $21 years) 
and baseline smoking (5–14 or $15 cigarettes/day) as given 
below.
First, a base model was constructed containing the mean 
β-carotene effect and a linear trend to adjust for the average 
reduction in common cold incidence with age. Then nine 
linear splines were added to both trial arms at 2-year intervals, 
starting at 54 years of age at follow-up. Thereafter, linear 
spline terms were added for the β-carotene arm to the same 
knots. This saturated model was simplified by dropping the 
knots that had the least effect on the β-carotene spline model, 
starting with those with the lowest Wald test χ2 value. Con-
currently, the corresponding knots covering both arms were 
dropped out. The models were simplified until all remain-
ing β-carotene arm knots made a significant contribution to 
the spline model (Wald test χ2 . 4). The final model thus 
contained knots at the same years for both arms to provide 
the baseline and for the β-carotene arm to provide the age 
modification of the β-carotene effect. If none of the knots 
were significant in the Wald test, the effect of β-carotene was 
reduced to a uniform effect that is constant over the studied 
age range. The statistical significance of the interaction 
between β-carotene effect and age at follow-up was calculated 
from the change in the −2 × log(likelihood) difference when 
comparing the final model and the model without knots in 
the β-carotene arm. The change in the −2 × log(likelihood) 
gives the χ2 value with the degrees of freedom defined by 
the number of knots in the final model.
To test the statistical significance of interaction between 
β-carotene supplementation and potential modifying factors 
in Tables 2–5, ie, heterogeneity, supplementation and the 
modifying factor were first added to the regression model. 
Thereafter, the interaction terms of β-carotene supplementa-
tion and the modifying factor were added to the model. The 
statistical significance of the interaction from the change 
in −2 × log(likelihood) was calculated, which gives the χ2 
value with degrees of freedom defined by the number of 
interaction terms in the model.
As to supplementation, the analyses were carried out 
following the intention-to-treat principle. Compliance with 





Table 3 The effect of β-carotene on common cold incidence; the ATBc Study 1985–1993: participants aged $70 years at the 
follow-up visit
Age of smoking  
initiation (years)
Cigarettes/day No. of  
participants






$21 5–14 178 1515 0.205 0.269 0.76 0.61, 0.94
$21 $15 325 2619 0.216 0.204 1.06 0.90, 1.26
#20 5–14 256 1960 0.236 0.235 1.00 0.83, 1.21
#20 $15 640 4354 0.218 0.187 1.16 1.02, 1.33
Notes: each participant visited the study center three times per year for evaluation of whether he had had common cold episodes after the preceding visit. Adding a uniform 
β-carotene effect onto all of the 10,448 visits at the follow-up age of $70 years yields rr = 1.03 (95% ci: 0.95, 1.13). Adding an individual β-carotene effect, shown in this 
table, to each of the four subgroups improves the Poisson model by χ2 (3 df) = 11.6, corresponding to P = 0.009. There is a significant interaction between baseline smoking 
and the effect of β-carotene (P = 0.007), and between the age of smoking initiation and the effect of β-carotene (P = 0.035). There is no second-order interaction between 
the age of smoking initiation and baseline smoking with the effect of β-carotene (P = 0.5).
Table 4 The effect of β-carotene on common cold incidence; 
ATBc Study participants aged $70 years: the age of smoking 
initiation $21 years and smoking 5–14 cigarettes per day at 
baseline
Subgroup No. of  
visits
RR of  
colds
95% CI Interaction P




  ,2.0 731 0.89 0.64, 1.23 0.5
  $2.0 710 0.77 0.58, 1.03
Weight (kg)
  ,60 125 0.42 0.21, 0.81 0.015
  60–84 1003 0.97 0.74, 1.26
  $85 387 0.57 0.37, 0.88
Alcohol (mL/day)*
  0 223 0.77 0.42, 1.37 0.9
  .0–9.9 877 0.76 0.58, 0.99
  $10 341 0.85 0.54, 1.34
Notes: *restricted to participants with data available on the variable. β-carotene 
intake level is cut close to the median.
Table 5 The effect of β-carotene on common cold incidence; 
ATBc Study participants aged $70 years: the age of smoking 
initiation #20 years and smoking $15 cigarettes per day at 
baseline
Subgroup No. of  
visits
RR of  
colds
95% CI Interaction P




  ,1.6 2035 1.39 1.14, 1.71 0.015
  $1.6 2054 1.00 0.82, 1.20
Weight (kg)
  ,60 400 1.05 0.67, 1.66 0.4
 60–84 2940 1.12 0.95, 1.31
  $85 1014 1.38 1.04, 1.85
Alcohol (mL/day)*
 0 743 1.88 1.31, 2.69 0.010
  .0–9.9 1724 1.13 0.91, 1.40
  $10 1622 1.00 0.82, 1.23
Notes: *restricted to participants with data available on the variable. β-carotene 
intake level is cut close to the median.
supplementation was high: about 80% of participants took 
more than 95% of their prescribed capsules during their 
active participation in the trial, and there were no differences 
in capsule consumption between the intervention arms.15,16 
The outcome was available only for those participants who 
continued with the trial and participated in the follow-up 
visits. Two-tailed P values were used.
Results
Table 1 shows the distributions for the baseline data for age, 
level of smoking, and age of smoking initiation and follow-up 
data for age at the follow-up visits. On an average, 0.27 com-
mon cold episodes were reported at each 4-month follow-up 
visit, corresponding to an annual rate of 0.8 cold episodes. 
With a particularly narrow CI, β-carotene had no overall 
effect on the incidence of colds in the whole participant 
population: RR = 1.009 (95% CI: 0.993, 1.026).
To test the potential modification of β-carotene effect 
by age, I constructed linear spline models for the β-carotene 
effect as a function of the age at follow-up separately for 
the four subgroups defined by the baseline smoking level 
and the age of smoking initiation (Figures 1 and 2). Three 
subgroups show statistically highly significant modification 
of β-carotene effect by age, whereas the subgroup of partici-
pants who initiated smoking at $21 years and smoked $15 
cigarettes per day at baseline does not show modification of 
β-carotene effect by age.
Based on the appearance of the spline curves, two 
age ranges were selected for calculating the estimates of 
the β-carotene supplementation effect and for testing the 
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modification of β-carotene effect by smoking. Among the 
50- 59-year-old participants, β-carotene increases the inci-
dence of colds in those who smoked 5–14 cigarettes per day, 
whereas it has no effect on those who smoked $15 cigarettes 
per day (Table 2). In this group, baseline smoking sig-
nificantly modifies the effect of β-carotene, but the age 
of smoking initiation does not (Table 2). There is statistically 
significant heterogeneity in the effect of β-carotene in the four 
subgroups among the 50- 59-year-old participants.
Among the $70-year-old participants, the effect of 
β-carotene diverges (Table 3). In this group, both baseline 
smoking and the age of smoking initiation significantly modify 
the effect of β-carotene, but the two measures of smoking 
exposure do not have interaction (Table 3). The greatest benefit 
of β-carotene is seen among those who initiated smoking 
at $21 years and smoked 5–14 cigarettes per day, whereas the 
greatest harm is seen in the reverse, ie, in those who started 
smoking at #20 years and smoked $15 cigarettes per day. 
Started smoking at ≥21 years




















Figure 1 rr of the common cold incidence in the β-carotene arm compared with the placebo arm. The ATBc Study 1985–1993: participants who started smoking 
at $21 years. Adding one knot to the spline curve of the participants who smoked 5–14 cigarettes per day at baseline improves the spline model by χ2 (1 df) = 11.9, 
corresponding to P = 0.0006. in the participants who smoked $15 cigarettes per day at baseline, no knot made a significant contribution to the form of the spline curve, 
which is located horizontally at rr = 1.03. The placebo arm level is indicated by the broken line at rr = 1.00.
Started smoking at ≤20 years




















Figure 2 rr of the common cold incidence in the β-carotene arm compared with the placebo arm. The ATBc Study 1985–1993: participants who started smoking 
at #20 years. Adding two knots to the spline curve of the participants who smoked 5–14 cigarettes per day at the baseline improves the regression model by χ2 (2 df) = 30.1, 
corresponding to P = 0.0000003. Adding four knots to the participants who smoked $15 cigarettes per day at baseline improves the regression model by χ2 (4 df) = 18.8, 
corresponding to P = 0.0009. The placebo arm level is indicated by the broken line at rr = 1.00.





The CI for the β-carotene effect on these two subgroups 
is  strikingly different (Table 3). In Tables 4 and 5, further 
possible modifications were explored in the subgroups 
of $70-year-old participants who had the greatest benefit 
and the greatest harm from β-carotene supplementation.
Among the $70-year-old participants who started 
smoking at $21 years and smoked 5–14 cigarettes per day, 
dietary β-carotene intake did not modify the effect of supple-
mentation (Table 4). The benefit of β-carotene supplementa-
tion was restricted to the low- and heavy-weight participants, 
whereas it had no effect on those with medium body weight. 
Alcohol intake did not modify the β-carotene effect.
Among the $70-year-old participants who had started 
smoking at #20 years and smoked $15 cigarettes per day, 
the interaction between dietary and supplement β-carotene 
was significant, the harm from the supplement being 
restricted to those who had low dietary β-carotene intake 
(Table 5). Weight did not significantly modify the effect 
of β-carotene, although the harm was more apparent in the 
heaviest participants. Alcohol intake modified the β-carotene 
effect, so that this effect was restricted to those who did not 
consume alcohol at all.
Discussion
In the ATBC Study, β-carotene supplementation had no 
overall effect on common cold incidence.10 However, the 
current study refutes the notion that the effect of β-carotene 
supplementation on common cold incidence is uniform 
over the whole ATBC Study population. In three of four 
subgroups defined by the exposure to cigarette smoking, 
the effect of β-carotene supplementation was significantly 
modified by age. Furthermore, β-carotene significantly 
reduced the incidence of colds among older participants 
who were least exposed to smoking, whereas among older 
participants who were most heavily exposed to smoking, 
β-carotene significantly increased the incidence of colds. 
The strong evidence indicating that the β-carotene effect on 
common cold incidence varies between population groups 
has important implications.
It has been pointed out that observational studies on vita-
mins, ie, case control and cohort studies, are often unreliable 
because diet is strongly associated with numerous lifestyle 
factors which cannot be fully adjusted for in statistical 
models.3,4 The ATBC Study was initiated because observa-
tional studies found reduced lung cancer risk in people who 
had a high dietary intake of β-carotene. However, the ATBC 
and CARET studies found, paradoxically, that β-carotene 
supplementation increased the incidence of lung cancer, 
thereby refuting the conclusions based on the observational 
studies.15,19 Similarly, meta-analyses of vitamin E trials20,21 
refuted the cohort studies suggesting that increased vitamin 
E intake would reduce the risk of cardiovascular diseases in 
large population groups.22,23
The variation in β-carotene supplementation effect 
between different population groups found in this study pro-
vides further evidence against the validity of observational 
studies in nutrition. Confounders are typically adjusted for 
statistically in observational studies, allowing calculation 
of a uniform effect across the population. However, the 
significant modification of the β-carotene effect by age 
and smoking means that the effect of β-carotene should 
be studied separately in groups defined by age and appro-
priate  measures of cigarette smoke exposure, rather than 
calculating a uniform effect adjusting for those variables as 
if they were confounders. The marked heterogeneity in the 
β-carotene effect on common cold incidence in the ATBC 
Study is thus a further refutation of the studies calculating 
correlations between the levels of dietary substances and the 
incidence of diseases. Large randomized trials such as the 
ATBC Study can give accurate estimates for subgroups, as 
shown by the current study and our earlier subgroup analyses 
of vitamin E supplementation effects.5–9,13,24 However, similar 
subgroup analyses in observational studies are much more 
challenging or impossible because of the close associations 
between dietary variables with each other and with numerous 
other lifestyle factors.3,4
A number of cohort studies have reported on the associa-
tion between dietary β-carotene intake and the incidence of 
respiratory tract infections suggesting that the relationship 
is uniform over the study population.6,10–12 The current find-
ings on the randomized groups of the ATBC Study refute the 
notion of uniformity, implying that the results of the cohort 
studies can be unreliable.
Another source of data for assessing the role of β-carotene 
on infections is available from the multivitamin supplement 
trials with elderly people.25–27 If there is no effect on  infections 
in a multivitamin trial, it seems justified to conclude that 
each vitamin of the supplement lacks an effect. The trials 
with multivitamin supplements containing 1.2–16 mg/day of 
β-carotene did not show a reduction in the number of respi-
ratory infections,25–27 implying that the increase in the level 
of β-carotene intake had no effect. Although the  negative 
findings in the multivitamin trials discourage multivitamin 
supplementation for the purpose of reducing infections 
among the elderly, the conclusions are limited by the small 
size of the trials. A great proportion of the participants in 
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the multivitamin trials were under 70, and the trials were 
small, with a maximum of 1024 infection episodes recorded 
by Graat et al.26 In the ATBC Study, β-carotene had no 
effect on participants somewhat older than 60, whereas it 
had significantly divergent effects on those more than 70. 
Figures 1 and 2 are based on 55,905 common cold episodes, 
which provide statistical power to carry out analyses of age 
dependency in the four subgroups. Thus, it may be justified 
to examine the effect of β-carotene on less smoking and 
nonsmoking males who are older than 70 years (Figure 2), 
even though the average effect in the ATBC Study was null 
and the β-carotene containing multivitamin supplements 
had no effects.25–27
A further implication of the current study is that it pro-
vides a strong argument against the opinion that subgroup 
analyses of controlled trials should be strongly discouraged 
because they can lead to false positive findings due to the 
multiple comparison problem.28 Biology is complex, and it 
seems unlikely that the belief in a uniform effect is usually 
justified. Given the long-term commitment of participants 
and the resources invested, it might even be considered as a 
duty of the researchers to analyze the large trial databases 
as extensively as possible rather than simply calculating 
an overall effect. Subgroup findings should obviously be 
considered cautiously, and the interpretation of P values 
must be related to the number of subgroup analyses being 
carried out. Nevertheless, the current subgroup findings of 
the ATBC Study suggest that further studies of β-carotene 
in males older than 70 years may be justified, although the 
overall estimate of RR = 1.009 indicates that no further 
studies would be worthwhile.
Exploratory subgroup analyses of the two groups of 
the old participants who showed the greatest harm and the 
greatest benefit from β-carotene supplementation were car-
ried out (Tables 4 and 5). Since a fixed β-carotene dose was 
used in the ATBC Study, the dose–response of β-carotene 
supplementation cannot be examined directly. Nevertheless, 
it can be explored indirectly by examining the variation in 
β-carotene effect by body weight. Previously, it was found 
that vitamin E supplementation increased the incidence of 
pneumonia among low-weight ATBC participants, but not 
among middle-weight participants, consistent with the dose–
response assumption.7 However, vitamin E also increased 
the incidence of pneumonia in the heaviest participants, 
which lacks a similar simple rationalization.7 Among the old 
ATBC Study participants who started smoking at a later age 
and smoked less at the baseline, the effect of β-carotene on 
common cold incidence was similarly restricted to the low 
and high ends of the body-weight scale (Table 4). Weight did 
not modify β-carotene effect among the heavy smokers who 
initiated smoking at an early age (Table 5).
Dietary β-carotene intake might influence the effect 
of β-carotene supplementation. There was a significant 
interaction between dietary and supplement β-carotene 
among heavy smokers who started smoking at an early age 
(Table 5); however, this modification might be caused by 
other substances in vegetables as well and does not imply 
specificity to β-carotene.
Previously, the increased risk of lung cancer with 
β-carotene supplementation was restricted to participants 
who had a high intake of alcohol.29 In this study, alcohol 
intake modified the effect of β-carotene on common cold 
incidence among heavy smokers who started smoking at 
an early age, so that the harm was restricted to teetotalers 
(Table 5).
The purpose of this study was to test whether the effect 
of β-carotene supplementation on common cold incidence is 
uniform among the ATBC Study population. The numerical 
estimates calculated for the subgroups are much less essential 
than the strong evidence of heterogeneity. Although the pri-
mary focus of this study was on age and smoking as variables 
potentially modifying the effect of β-carotene supplemen-
tation, Tables 4 and 5 indicate that many more variables 
may modify the supplementation effect. When the effect of 
β-carotene supplementation depends on individual charac-
teristics, the estimates of effect obtained in one study cannot 
be confidently generalized to other population groups.
Conclusions
The main finding of this study is that β-carotene supple-
mentation may increase, decrease, or have no effect on the 
incidence of common cold among male smokers depending 
on age and the level of smoking exposure. It is premature to 
draw any practical conclusions from the current subgroup 
findings, but the strong evidence of heterogeneity in the 
β-carotene supplementation effect challenges the validity of 
observational studies in nutrition, because they are usually 
based on the assumption of a uniform effect over the study 
population.
Acknowledgments
The author thanks the ATBC Study (The National Institute for 
Health and Welfare, Finland, and National Cancer Institute, 
USA) for the access to the data. The author had full access 
to all of the data in this study, and takes responsibility for the 
accuracy of the data analysis.
Nutrition and Dietary Supplements
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/nutrition-and-dietary-supplements-journal
Nutrition and Dietary Supplements is an international, peer-reviewed, 
open access journal focusing on research into nutritional requirements 
in health and disease, impact on metabolism and the identification and 
optimal use of dietary strategies and supplements necessary for nor-
mal growth and development. The journal welcomes papers covering 
original research, basic science, clinical & epidemiological studies, 
reviews and evaluations, guidelines, expert opinion and commentary, 
case reports and extended reports. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use.







This study was not funded by sources outside of our 
u niversity. The author reports no conflicts of interest.
References
 1. Vandenbroucke JP. Observational research, randomised trials, and 
two views of medical science. PLoS Med. 2008;5:e67.
 2. Stram DO, Huberman M, Wu AH. Is residual confounding a reasonable 
explanation for the apparent protective effects of beta-carotene found 
in epidemiologic studies of lung cancer in smokers? Am J Epidemiol. 
2002;155:622–628.
 3. Lawlor DA, Davey Smith G, Kundu D, Bruckdorfer KR, Ebrahim S. 
Those confounded vitamins: what can we learn from the differences 
between observational versus randomised trial evidence? Lancet. 2004; 
363:1724–1727.
 4. Smith GD, Lawlor DA, Harbord R, Timpson N, Day I, Ebrahim S. 
Clustered environments and randomized genes: a fundamental dis-
tinction between conventional and genetic epidemiology. PLoS Med. 
2007;4:e352.
 5. Hemilä H, Virtamo J, Albanes D, Kaprio J. The effect of vitamin E on 
common cold incidence is modified by age, smoking and residential 
neighborhood. J Am Coll Nutr. 2006;25:332–339.
 6. Hemilä H, Virtamo J, Albanes D, Kaprio J. Vitamin E and beta-carotene 
supplementation and hospital-treated pneumonia incidence in male 
smokers. Chest. 2004;125:557–565.
 7. Hemilä H, Kaprio J. Vitamin E supplementation and pneumonia risk 
in males who initiated smoking at an early age: effect modification by 
body weight and dietary vitamin C. Nutr J. 2008;7:33.
 8. Hemilä H. Do Vitamins C and E Affect Respiratory Infections? PhD 
Thesis. Helsinki, Finland: University of Helsinki; 2006:56–57. Available 
from: http://ethesis.helsinki.fi/julkaisut/laa/kansa/vk/hemila/. Accessed 
Aug 4, 2010.
 9. Hemilä H, Kaprio J. Vitamin E supplementation may transiently 
increase tuberculosis risk in males who smoke heavily and have high 
dietary vitamin C intake. Br J Nutr. 2008;100:896–902. Comments in: 
Br J Nutr. 2008;101:145–147.
 10. Hemilä H, Kaprio J, Albanes D, Heinonen OP, Virtamo J. Vitamin C, 
vitamin E, and beta-carotene in relation to common cold incidence in 
male smokers. Epidemiology. 2002;13:32–37.
 11. Merchant AT, Curhan G, Bendich A, Singh VN, Willett WC, Fawzi WW. 
Vitamin intake is not associated with community-acquired pneumonia 
in US men. J Nutr. 2004;134:439–444.
 12. Neuman MI, Willett WC, Curhan GC. Vitamin and micronutrient 
intake and the risk of community-acquired pneumonia in US women. 
Am J Med. 2007;120:330–336.
 13. Hemilä H, Virtamo J, Albanes D, Kaprio J. Physical activity and the 
common cold in men administered vitamin E and β-carotene. Med Sci 
Sports Exerc. 2003;35:1815–1820.
 14. Greenland S. Dose-response and trend analysis in epidemiology: alter-
natives to categorical analysis. Epidemiology. 1995;6:356–365.
 15. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. 
The effect of vitamin E and beta-carotene on the incidence of lung 
cancer and other cancers in male smokers. N Engl J Med. 1994;330: 
1029–1035.
 16. The ATBC Cancer Prevention Study Group. The alpha-tocopherol, 
beta-carotene lung cancer prevention study: design, methods, participant 
characteristics, and compliance. Ann Epidemiol. 1994;4:1–10.
 17. Pietinen P, Hartman AM, Haapa E, et al. Reproducibility and validity of 
dietary assessment instruments. A self-administered food use question-
naire with a portion size picture booklet. Am J Epidemiol. 1988;128: 
655–666.
 18. Gwaltney JM. The common cold. In: Mandell GL, Bennett JE, 
Dolin R, editors. Principles and Practice of Infectious Diseases. 5th ed. 
New York, NY: Churchill Livingstone; 2000:651–656.
 19. Omenn GS. Chemoprevention of lung cancer: the rise and demise of 
beta-carotene. Annu Rev Public Health. 1998;19:73–99.
 20. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. 
Randomized trials of vitamin E in the treatment and prevention of 
cardiovascular disease. Arch Intern Med. 2004;164:1552–1556.
 21. Shekelle PG, Morton SC, Jungvig LK, et al. Effect of supplemental 
vitamin E for the prevention and treatment of cardiovascular disease. 
J Gen Intern Med. 2004;19:380–389.
 22. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, 
Willett WC. Vitamin E consumption and the risk of coronary disease 
in women. N Engl J Med. 1993;328:1444–1449.
 23. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, 
 Willett WC. Vitamin E consumption and the risk of coronary heart 
disease in men. N Engl J Med. 1993;328:1450–1456.
 24. Hemilä H, Kaprio J. The effect of vitamin E supplementation on the 
mortality of male smokers is modified by age and dietary vitamin C. 
Am J Epidemiol. 2009;169:946–953.
 25. Girodon F, Galan P, Monget AL, et al. Impact of trace elements and 
vitamin supplementation on immunity and infections in institutionalized 
elderly patients. Arch Intern Med. 1999;159:748–754.
 26. Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multi-
vitamin-mineral supplementation on acute respiratory tract infections 
in elderly persons: a randomized controlled trial. JAMA. 2002;288: 
715–721.
 27. Liu BA, McGeer A, McArthur MA, et al. Effect of multivitamin and 
mineral supplementation on episodes of infection in nursing home 
residents: a randomized, placebo-controlled study. J Am Geriatr 
Soc. 2007;55:35–42. Correction in: J Am Geriatr Soc. 2007;55:478. 
 Discussion in: J Am Geriatr Soc. 2007;55:1311–1314.
 28. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and 
other (mis)uses of baseline data in clinical trials. Lancet. 2000;355: 
1064–1069.
 29. Albanes D, Heinonen OP, Taylor PR, et al. Alpha-tocopherol and 
beta-carotene supplements and lung cancer incidence in the alpha-
tocopherol, beta-carotene cancer prevention study: effects of base-line 
characteristics and study compliance. J Natl Cancer Inst. 1996;88: 
1560–1570.
